Home/Recalls/FDA-D-0619-2026
FDA DrugsClass III

hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx on...

Published: July 1, 2026Recall ID: D-0619-2026Category: drugsCountry: US

Reason for Recall / Hazard

Presence of foreign substance

Product Description & Identification

hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10

Affected Products

hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10

Additional Source Details

FieldValue
CityBaudette
StateMN
Openfda › Upc0370954912101
Openfda › Unii76755771U3
Openfda › RouteORAL
Openfda › Rxcui995241
Openfda › Spl id43889411-a303-41a1-b03b-1ee46f452c54
Openfda › Brand nameHYDROXYZINE HYDROCHLORIDE
Openfda › Spl set id43889411-a303-41a1-b03b-1ee46f452c54
Openfda › Package ndc70954-912-10
Openfda › Product ndc70954-912
Openfda › Generic nameHYDROXYZINE HYDROCHLORIDE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameHYDROXYZINE DIHYDROCHLORIDE
Openfda › Manufacturer nameANI Pharmaceuticals, Inc.
Openfda › Application numberANDA219648
Openfda › Is original packagertrue
Event id99131
Address 1210 W Main St
Address 2N/A
Code infoLot S25133A
Postal code56623-2467
Report date20260701
Product typeDrugs
Product quantity6564 bottles
Reason for recallPresence of foreign substance
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260602
Initial firm notificationLetter
Center classification date20260624

Overview

  • Recalling FirmANI Pharmaceuticals, Inc.
  • StatusOngoing
  • Risk LevelClass III
  • DistributionNationwide in the USA
Official Agency Alert